| Literature DB >> 27069930 |
Martin Röhling1, Christian Herder1, Theodor Stemper2, Karsten Müssig3.
Abstract
Insulin resistance plays a key role in the development of type 2 diabetes. It arises from a combination of genetic predisposition and environmental and lifestyle factors including lack of physical exercise and poor nutrition habits. The increased risk of type 2 diabetes is molecularly based on defects in insulin signaling, insulin secretion, and inflammation. The present review aims to give an overview on the molecular mechanisms underlying the uptake of glucose and related signaling pathways after acute and chronic exercise. Physical exercise, as crucial part in the prevention and treatment of diabetes, has marked acute and chronic effects on glucose disposal and related inflammatory signaling pathways. Exercise can stimulate molecular signaling pathways leading to glucose transport into the cell. Furthermore, physical exercise has the potential to modulate inflammatory processes by affecting specific inflammatory signaling pathways which can interfere with signaling pathways of the glucose uptake. The intensity of physical training appears to be the primary determinant of the degree of metabolic improvement modulating the molecular signaling pathways in a dose-response pattern, whereas training modality seems to have a secondary role.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27069930 PMCID: PMC4812462 DOI: 10.1155/2016/2868652
Source DB: PubMed Journal: J Diabetes Res Impact factor: 4.011
Effect of acute and chronic exercise on molecular signaling pathways.
| Metabolic factor | Acute training | Chronic training | Exercise characteristics (intensity, modality) | References |
|---|---|---|---|---|
| Proximal insulin signaling (IRS-1, PI3-K, PDK, | ↑ | ↑↑ | Moderate-to-intensive exercise for untrained and high-intensity exercise for trained individuals, independent of modality | [ |
|
| ||||
| AMPK | ↑↑ | ↑↑ | Dose-response pattern, independent of modality | [ |
|
| ||||
| Ca2+-calmodulin axis | ↑↑ | ↑↑ | Dose-response pattern, independent of modality | [ |
|
| ||||
| mTOR/S6K | ↑↑ | ↑↑ | Dose-response pattern, independent of modality | [ |
|
| ||||
| Downstream targets: AS160, TBC1D1, Rac1 | ↑ | ↑ | Dose-response pattern for AS160 and Rac1, independent of modality | [ |
|
| ||||
| IKK/NF- | ↑↕$ | ↓↓ | Dose-response pattern, independent of modality | [ |
|
| ||||
| Inflammasome pathway | — | ↓↓ | Dose-response pattern, independent of modality | [ |
|
| ||||
| JNK/MAPK pathway | ↑↑ | ↓↓ | Dose-response pattern, independent of modality | [ |
|
| ||||
| Adiponectin | ↑ | ↑ | Intense exercise, independent of modality | [ |
↑↑/↓↓, consistent findings in animal models and humans; ↑/↓, preliminary evidence from animal models and/or humans; —, no impact; animal studies showed no effects; $increase in skeletal muscle and increase/decrease in adipose tissue; αPKC, atypical PKC; AMPK, AMP-activated protein kinase; AS160, Akt substrate of 160 kDa; Ca, calcium; CaMKII, Ca2+/calmodulin-dependent protein kinase 2; IRS-1, insulin receptor substrate 1; IKK/NF-κB, IκB kinase/nuclear factor kappa B; JNK, C-Jun N-terminal kinase; MAPK, mitogen-activated protein kinases; mTOR/S6K, mammalian target of rapamycin/ribosomal S6 kinase; PDK, phosphoinositide-dependent kinase; PI3-K, phosphoinositide 3-kinase; Rac1, ras-related C3 botulinum toxin substrate 1; TBC1D1, TBC1 domain family member 1.
Influence of exercise on glucose uptake-related signaling pathways in humans.
| Reference | Study population, | Age, years | Training modality | Type of sport | Training frequency | Acute/chronic exercise | Training intensity | Tissue & condition | Time since the last exercise bout, h | Changes in glucose uptake and related molecular signaling |
|---|---|---|---|---|---|---|---|---|---|---|
| Cusi et al., 2000 [ | 9 untrained obese CON, | 44 ± 4 | ET | Cycling | 60 min | Acute | 65% VO2max | Muscle & insulin-stimulated (clamp) | 24 h after exercise | Increase of insulin receptor (+60% in obese CON, +34% in T2D) and IRS-1 tyrosine phosphorylation (+20% in T2D) |
|
| ||||||||||
| Howlett et al., 2006 [ | 7 untrained CON | 24 ± 2 | ET | Cycling | 60 min | Acute | 75% VO2max | Muscle & insulin-stimulated (clamp) | Immediately after exercise, and at 30 and 120 minutes of clamp | Increase of insulin-stimulated IRS-2 signaling (IRS-2-associated PI3–kinase activity) after exercise |
|
| ||||||||||
| Perseghin et al., 1996 [ | 10 untrained lean offspring T2D, | 33 ± 3 | ET | Stair-climbing machine | 45 min | Acute | 65% VO2max | Muscle & insulin-stimulated (clamp) | 48 h after exercise | Increase of glucose disposal by 35% in the offspring and 41% in CON |
|
| ||||||||||
| Wojtaszewski et al., 2000 [ | 7 trained CON | 22 ± 1 | ET | One-leg-exercise | 60 min | Acute | 18–23% VO2max | Muscle & insulin-stimulated (clamp) | After 7, 15, 60, 120, 150 min of exercise | No change in proximal insulin signaling, but exercise induced increase of glucose uptake up to 2-to-4-fold higher compared to rested leg |
|
| ||||||||||
| Musi et al., 2001 [ | 7 untrained lean T2D, | 53 ± 3 | ET | Cycling | 45 min | Acute | 70% of | Muscle | During and immediately after exercise | Similar protein expression of AMPK |
|
| ||||||||||
| Gibala et al., 2009 [ | 6 trained CON | 23 ± 2 | HIT | Cycling | 20 min | Acute | 4 × 30 s “all-out” sprint | Muscle | Immediately and 3 h after exercise | Increase of AMPK (30%), AMPK |
|
| ||||||||||
| Sriwijitkamol et al., 2007 [ | 8 CON, | 45 ± 3 | ET | Cycling | 40 min | Acute | 50–70% VO2max | Muscle | During and immediately after exercise | AMPK activity only improved in lean CON in a dose-response manner |
|
| ||||||||||
| Benziane et al., 2008 [ | 9 untrained CON | 23 ± 2 | ET | Cycling | 60 min | Acute | 164 W (intense) | Muscle | Immediately and 3 h after exercise | Increase of AMPK (16.0-fold) and mTOR (2.0-fold) phosphorylation after exercise and abrogation of AMPK phosphorylation and mTOR phosphorylation after 3 h of exercise |
|
| ||||||||||
| Egan et al., 2010 [ | 8 sedentary CON | 25 ± 1 | ET | Cycling | n.r. | Acute | 40/80% VO2max
| Muscle | Immediately, 3 h and 19 h after exercise | Increase of AMPK (2.8-fold) and CaMKII (84%) phosphorylation immediately after high-intensity but not low-intensity exercise |
|
| ||||||||||
| Rose et al., 2006 [ | 8 trained CON | 25 ± 1 | ET | Cycling | 90 min | Acute | 67% VO2max | Muscle | At rest and after 1, 10, 30, 60, and 90 min of exercise | Increase of CaMKII activity during exercise depending on exercise duration (2-fold) |
|
| ||||||||||
| Rose et al., 2006 [ | 10 trained CON | 25 ± 2 | ET | Cycling | 30 min | Acute | 35%, 60%, 85% VO2max | Muscle | Immediately and 30 min after exercise | Increase of CaMKII phosphorylation during exercise depending on exercise intensity (1 to 3-fold) |
|
| ||||||||||
| Combes et al., 2015 [ | 9 trained CON | 22 ± 5 | ET/HIT | Cycling | 30 min/30 × 1 min | Acute | 70% of | Muscle | Immediately and 3 h after exercise | Increase of CaMKII phosphorylation by 2.7-fold after HIT compared to continuous exercise (same work rate) |
|
| ||||||||||
| Fujita et al., 2007 [ | 6 untrained CON | 70 ± 2 | ET | Treadmill walking | 45 min | Acute | 70% of HRmax | Muscle & insulin-stimulated (clamp) | 20 h after exercise | Increase of mTor activity (5.0-fold) after 20 h of rest under insulin stimulation |
|
| ||||||||||
| Camera et al., 2010 [ | 8 trained CON | 29 ± 2 | ET | Cycling | 60 min | Acute | 70% VO2max | Muscle | Immediately, 15, 30, and 60 min after exercise | Increase of mTOR phosphorylation (100%) that peaked 30–60 min after exercise termination, workload (660 kcal) |
|
| ||||||||||
| Camera et al., 2010 [ | 8 trained CON | 28 ± 2 | RT | Leg extension | 8 × 5 repetitions | Acute | 80% 1-RM | Muscle | Immediately, 15, 30, and 60 min after exercise | Increase of mTOR phosphorylation (100%) that peaked 30–60 min after exercise termination, workload (130 kcal) |
|
| ||||||||||
| Mascher et al., 2011 [ | 16 untrained CON | 23 ± 2 | ET | One-leg cycling | 60 min | Acute | 65–70% VO2max of one leg | Muscle | Immediately, 90 and 180 min after exercise | Time-dependent increase of mTOR phosphorylation after 180 min of recovery by 60% compared to resting situation |
|
| ||||||||||
| Pugh et al., 2015 [ | 10 untrained CON | 21 ± 1 | RT | Leg extension | 4 × 8 repetitions | Acute | 70% 1-RM | Muscle | 2 h and 6 h after exercise | No change of mTOR after RT alone |
|
| ||||||||||
| Pugh et al., 2015 [ | 10 untrained CON | 21 ± 1 | RT + HIT | Leg extension + cycling | 4 × 8 repetitions + 20 min | Acute | 70% 1-RM + 10 times 1 min | Muscle | 2 h and 6 h after exercise | RT + HIT: increase of mTOR phosphorylation by 30% compared to resistance training alone |
|
| ||||||||||
| Dreyer et al., 2006 [ | 11 untrained CON | 27 ± 2 | RT | Leg extension | 10 × 10 repetitions | Acute | 70% 1-RM | Muscle | During and 2 h after exercise | Increase of AMPK phosphorylation (50%) until 1 h after exercise and progressive increase of mTOR phosphorylation up to 100% at 2 h after exercise |
|
| ||||||||||
| Deshmukh et al., 2006 [ | 9 trained CON | 29 ± 6 | ET | Cycling | 60 min | Acute | 70% VO2max | Muscle | Immediately after exercise | Increase of Akt (80%) and AS160 (100%) phosphorylation in endurance trained young athletes after exercise |
|
| ||||||||||
| Deshmukh et al., 2006 [ | 9 trained CON | 29 ± 6 | RT | Isokinetic leg extension | 8 × 5 repetitions | Acute | Maximal voluntary isokinetic leg extensions | Muscle | Immediately after exercise | No change of Akt and AS160 in endurance trained young athletes after exercise |
|
| ||||||||||
| Treebak et al., 2007 [ | 30 trained CON | 26 ± 1 | ET | Cycling | 20 min, | Acute | 222 W | Muscle | Immediately after exercise | No change in AS160 phosphorylation in all 3 study arms |
|
| ||||||||||
| Treebak et al., 2007 [ | 8 trained CON | 25 ± 1 | ET | Cycling | 90 min | Acute | 67% VO2max | Muscle | Immediately after exercise | Increase of AS160 phosphorylation (120%) |
|
| ||||||||||
| Treebak et al., 2009 [ | 12 trained CON | 26 ± 1 | ET | One-leg-exercise | 60 min | Acute | 80% of | Muscle | 4 h after exercise | Increase of AS160 phosphorylation in exercised leg by 20–40% |
|
| ||||||||||
| Sylow et al., 2014 [ | 9 CON | n.r. | ET | Inclined walking | 45 min | Acute | 69% VO2max | Muscle | Immediately after exercise | Increase of Rac1 activity by 38% in m. soleus and 52% in m. gastrocnemius; increase of p-Rac1-Ser71 phosphorylation by 39% in m. soleus and by 20% in m. gastrocnemius |
|
| ||||||||||
| Vendelbo et al., 2014 [ | 8 trained CON | 26 ± 4 | ET | Cycling | 60 min | Acute | 65% VO2max | Muscle | 30 min and 4 h after exercise | Increase of AS160 and TBC1D1 phosphorylation 30 min after exercise |
|
| ||||||||||
| O'Gorman et al., 2006 [ | 7 obese CON, | 48 ± 4 | ET | Cycling | 60 min | Acute | 75% VO2max | Muscle & insulin-stimulated (clamp) | 16 h after exercise | Increase of glucose disposal by 36% in T2D, but not CON, no change in proximal signaling |
|
| ||||||||||
| Wadley et al., 2007 [ | 8 untrained CON | 24 ± 1 | ET | Cycling | 60 min | Acute | 75% VO2max | Muscle & insulin-stimulated (clamp) | 24 h after exercise | No change of insulin receptor & IRS-1 tyrosine phosphorylation after either acute or short-term training |
|
| ||||||||||
| Frøsig et al., 2007 [ | 8 trained CON | 25 ± 1 | ET | One-legged knee extensor apparatus | 60–120 min | Short-term (21 days) | 70–85% peak work load | Muscle & insulin-stimulated (clamp) | Immediately, 10 and 120 min under insulin after exercise | Increase of Akt1/2 and AS160 protein content by 55% and 25%, but, under insulin stimulation, no exercise effect |
|
| ||||||||||
| Perseghin et al., 1996 [ | 10 untrained lean offspring T2D, | 33 ± 3 | ET | Stair-climbing machine | 4 × 45 min | Chronic | 65% VO2max | Muscle & insulin-stimulated (clamp) | 48 h after exercise | Increase of glucose uptake by 76% in offspring and 58% in CON |
|
| ||||||||||
| Holten et al., 2004 [ | 10 untrained overweight T2D, | 62 ± 3 | RT | Leg training program | 3 × 30 min | Chronic | 50% 1-RM - 70–80% 1-RM | Muscle & insulin-stimulated (clamp) | 16 h after exercise | 40% increase in GLUT4 protein content in T2D, no change in CON; increase of protein content of insulin receptor by 19% (CON) and 21% (T2D), increase of PKB- |
|
| ||||||||||
| Consitt et al., 2013 [ | 21 sedentary CON | 18–84 | ET | Running | 3 × 60 min | Chronic (10 weeks) | 75% VO2max | Muscle & insulin-stimulated (clamp) | 40 h after exercise | Increase of whole-body insulin action and insulin-stimulated AS160 phosphorylation after exercise by 60% in young and 75% in insulin resistant CON |
|
| ||||||||||
| Consitt et al., 2013 [ | 22 sedentary CON | 20–82 | RT | Upper and lower body | 3 × 45 min | Chronic (10 weeks) | 12-RM | Muscle & insulin-stimulated (clamp) | 40 h after exercise | Increase of whole-body insulin action and insulin-stimulated AS160 phosphorylation after exercise by 75% in young & old individuals |
|
| ||||||||||
| Vissing et al., 2013 [ | 24 untrained CON | 23 ± 1 | ET/HIT | Cycling | 3 × 40 min | Chronic (10 weeks) | 65%–90% of | Muscle | Immediately, 15, 30, 60, and 120 min after exercise | Increase of AMPK phosphorylation by 44% after ET |
|
| ||||||||||
| Vissing et al., 2013 [ | 24 untrained CON | 23 ± 1 | RT | 3 leg-exercises | 3 × 8 × 5 repetitions | Chronic (10 weeks) | 4-5-RM | Muscle | Immediately, 15, 30, 60, and 120 min after exercise | Increase of AMPK phosphorylation by 10% and increase of mTOR/p70SK6 phosphorylation after 2 h up to 22 h by 91%–281% |
|
| ||||||||||
| Nitert et al., 2012 [ | 13 sedentary CON (positive family history (FH+)) | 37 ± 4 | ET | Cycling/aerobic exercise | 3 × 60 min | Chronic (26 weeks) | n.r. | Muscle | 48 h after exercise | Decrease of DNA methylation of genes of calcium signaling pathway after exercise in individuals with FH+ |
|
| ||||||||||
| Stuart et al., 2010 [ | 6 sedentary CON | 37 ± 3 | ET | Cycling | 30–70 min | Chronic (6 weeks) | 70%–85% of HRmax | Muscle | 40–48 h after exercise | Increase of GLUT4 by 66% and phosphor-mTOR by 83% |
Data are given as mean ± SD for age; all changes given in the table were statistically significant; 1-RM, one repetition maximum; AMPK, AMP-activated protein kinase; AS160, Akt substrate of 160 kDa; Ca, calcium; CaMKII, Ca2+/calmodulin-dependent protein kinase 2; CON, controls; ET, endurance training; HIT, high-intensity interval training, HRmax maximum heart rate, IRS-1/2, insulin receptor substrate 1/2; mTOR, mammalian target of rapamycin (C1 complex 1 & C2 complex 2); n.r., not reported; PDK, phosphoinositide-dependent kinase; PI3-K, phosphoinositide 3-kinase; PKB, protein kinase B; Rac1, ras-related C3 botulinum toxin substrate 1; RM, repetition maximum; RT, resistance training; T2D, type 2 diabetes; TBC1D1, TBC1 domain family member 1; VO2max, maximum oxygen consumption, W max, maximum Watt.
Influence of exercise on glucose uptake-related signaling pathways in animal models.
| Reference | Animals, | Age, week | Training modality | Type of sport | Training frequency | Acute/chronic exercise | Training intensity | Tissue & condition | Time since the last exercise bout, h | Changes in glucose uptake-related molecular signaling |
|---|---|---|---|---|---|---|---|---|---|---|
| Treadway et al., 1989 [ | Male Sprague-Dawley rats | n.r. | ET | Treadmill running | 45 min | Acute | 18 m/min | Insulin stimulated muscle | Immediately after exercise | No effect on insulin binding, basal and insulin-stimulated receptor autophosphorylation, or basal and insulin-stimulated exogenous kinase activity |
|
| ||||||||||
| Goodyear et al., 1995 [ | Male Sprague-Dawley rats | n.r. | ES | Contraction | n.r. | Acute | Training duration, 500 ms; pulse rate, 100 Hz; duration, 0.1 ms at 1–3 V | Insulin stimulated muscle | Immediately after contraction phase | Decrease of insulin-stimulated tyrosine phosphorylation and PI3-kinase activity (20%), no effect of exercise without insulin |
|
| ||||||||||
| Sakamoto et al., 2002 [ | Male Sprague-Dawley rats | n.r. | ES | Contraction | n.r. | Acute | Training rate, 1/s; train duration, 500 ms; pulse rate, 100 Hz; duration, 0.1 ms at 2–5 V | Muscle | Immediately after contraction phase | Increase of Akt Ser473 phosphorylation after 5 min (3-fold) and decrease to +23% after 30 min |
|
| ||||||||||
| Wojtaszewski et al., 1999 [ | Male muscle-specific insulin receptor knockout mice | 9-10 | ET | Treadmill running | 60 min | Acute | 22 m/min with 10% incline | Insulin stimulated muscle | Immediately after exercise | Increase of insulin-stimulated glucose transport without improvement of proximal insulin signaling, but increase of Akt phosphorylation (6.0-fold) |
|
| ||||||||||
| Castorena et al., 2014 [ | Male Wistar rats (LFD and HFD) | n.r. | ET | Swimming | 4 × 30 min | Acute | n.r. | Insulin stimulated muscle | Immediately and 3 h after exercise phase | Increase of AS160 immediately (2.0–2.5-fold) and after 3 h (3-fold, in LFD) |
|
| ||||||||||
| Bruss et al., 2005 [ | Male Wistar rats | n.r. | ES | Contraction | n.r. | Acute | Training rate, 2/min; training duration, 10 s; pulse rate, 100 Hz; duration, 0.1 ms at 2–5 V | Muscle | Immediately after contraction phase | Increase of AS160 phosphorylation (3.7-fold) |
|
| ||||||||||
| Fujii et al., 2005 [ | Muscle-specific transgenic knockout of | 10–16 | ES | Contraction | 10 min | Acute | Training rate, 1/min; training duration, 10 s; pulse rate, 100 Hz; duration, 0.1 ms at 100 V | Muscle | Immediately after contraction phase | Near normal glucose uptake (−13%) in KO mice |
|
| ||||||||||
| Jeppesen et al., 2013 [ | Muscle specific knockout of LKB1 mice | 16–20 | ET | Treadmill running | 24 min | Acute | 12.5 m/min | Muscle | Immediately after contraction phase | Normal glucose uptake in LKB1 deficient mice |
|
| ||||||||||
| Lefort et al., 2008 [ | Muscle-specific transgenic knockout of | n.r. | ES | Contraction | 2 min | Acute | Training rate, 1/s; training duration, 500 ms; pulse rate, 100 Hz; at 30 V | Muscle | Immediately after contraction phase | No change of AMPK activity after contraction, but increase of glucose uptake by 50% compared to CON mice |
|
| ||||||||||
| Sakamoto et al., 2005 [ | Muscle specific knockout of LKB1 mice | n.r. | ES | Contraction | 5 min | Acute | Training rate, 1/s; training duration, 200 ms; pulse rate, 50 Hz; duration, 0.1 ms at 2–5 V | Muscle | Immediately after contraction phase | Reduced glucose uptake in LKB1 deficient mice |
|
| ||||||||||
| Thomson et al., 2008 [ | Fischer 344 × Brown Norway male rats | 32 | ES | Contraction | 22 min | Acute | 10 sets 6 contractions for 3 s | Muscle | Immediately and 20, and 40 min after contraction phase | Increase of AMPK activity and inhibition of mTOR signaling |
|
| ||||||||||
| Katta et al., 2009 [ | 12 male lean normal Zucker rats, 12 male young obese Syndrome × Zucker rats | 10 | ES | n.r. | 22 min | Acute | 10 sets of 6 contractions | Muscle | Immediately, 1 h and 3 h after exercise | Increase of mTOR phosphorylation (Ser2448, 63%) and p70S6K (Thr389, 37%) compared to lean normal Zucker rats |
|
| ||||||||||
| Sylow et al., 2013 [ | Female C57BL/6 mice | 12–16 | ET | Treadmill running | 50%–70% maximal running speed 30 min | Acute | 16 m/min | Muscle | Immediately after exercise | Increase of Rac1 activity by 44%/50%/100% after 40%/50%/70% of maximal speed |
|
| ||||||||||
| Witczak et al., 2007 [ | Female ICR mice | 8 | ES | Contraction | 15 min | Acute | n.r. | Muscle | 45 min after contraction | No change in insulin-stimulated glucose uptake in calmodulin-binding domain-mutant mice, decrease of contraction-stimulated glucose uptake in calmodulin-binding domain-mutant mice |
|
| ||||||||||
| Witczak et al., 2010 [ | Female ICR mice | 6–8 | ES | Contraction | 10 min | Acute | Training rate, 1/min; training duration, 10 s; pulse rate, 100 pulses/s; duration, 0.1 ms; volts, 100 V | Muscle | 45 min after contraction | Decrease of contraction-induced muscle glucose uptake (30%) |
|
| ||||||||||
| Edgett et al., 2013 [ | Female Sprague-Dawley rats | n.r. | ET | Treadmill running | 120 min | Acute | 15 m/min + 5 m/min every 5 min | Muscle | Immediately and 3 h after exercise | Time-dependent increase of mTOR mRNA by 44% after 180 min of recovery |
|
| ||||||||||
| Edgett et al., 2013 [ | Female Sprague-Dawley rats | n.r. | ES | Contraction | 120 min | Chronic (7 days) | n.r. | Muscle | Immediately and 3 h after exercise | Increase of mTOR phosphorylation by 74% after 7 days of ES |
|
| ||||||||||
| Calegari et al., 2011 [ | 20 male Wistar rats | 8 | ET | Treadmill running | 5–60 min | Chronic (8 weeks) | 5 m/min–30 m/min | Pancreatic islets | 24 h after exercise | Increase of AMPK phosphorylation (100%) and CaMKII phosphorylation (+50%) |
|
| ||||||||||
| Luo et al., 2013 [ | Male Sprague-Dawley rats | 18–20 | RT | Ladder climbing with weights | 3 × 10 repetitions | Chronic (9 weeks) | 10% per week increase of additional weight | Muscle | 48 h after exercise | Increase of both total and phosphorylated AMPK compared to sedentary control |
|
| ||||||||||
| Ritchie et al., 2014 [ | Male wild-type (WT, C57BL/6J) mice, adiponectin knockout (AdKO, B6.129-Adipoqtm1Chan/J) mice | 12 | ET | Treadmill running | 3 × 45–60 min | Chronic (8 weeks) | 20–32 m/min | Insulin stimulated muscle | 48 h after exercise | Increase in total AS160 phosphorylation from AdKO (44%) compared to WT mice (28%); |
All changes given in the table were statistically significant; AMPK, AMP-activated protein kinase; AS160, Akt substrate of 160 kDa; Ca, calcium; CaMKII, Ca2+/calmodulin-dependent protein kinase 2; CON, controls; DIO, diet-induced obesity; ES, electrical stimulation; ET, endurance training; GLUT4, glucose transporter 4; HFD, high fed diet; LFD, low fed diet; LKB-1, liver kinase B1; mTOR, mammalian target of rapamycin (C1 complex 1 & C2 complex 2); n.r., not reported; PI3-K, phosphoinositide 3-kinase; Rac1, ras-related C3 botulinum toxin substrate 1; RT, resistance training; SK6, serine kinase 6; T2D, type 2 diabetes; TBC1D1, TBC1 domain family member 1.
Influence of exercise on inflammatory signaling and adiponectin in humans.
| Reference | Study population, | Age, years | Training modality | Type of sport | Training frequency | Acute/chronic exercise | Training intensity | Tissue & condition | Time since the last exercise bout, h | Changes in cytokines and related inflammatory signaling |
|---|---|---|---|---|---|---|---|---|---|---|
| Lancaster et al., 2005 [ | 11 trained CON | 25 ± 1 | ET | Cycling | 90 min | Acute | 65% VO2max + 34°C radiation | Plasma | Immediately and 2 h after exercise | Increase in IL-6 plasma levels in response to LPS stimulation after exercise |
|
| ||||||||||
| Leggate et al., 2010 [ | 11 trained CON | 22 ± 4 | ET | Cycling | 60 min | Acute | 62% VO2max
| Plasma | Immediately, 1.5, 6 and 23 h after exercise | Increase of soluble interleukin-6 receptor complex after continuous ET (126%) |
|
| ||||||||||
| Leggate et al., 2010 [ | 11 trained CON | 22 ± 4 | HIT | Cycling | 4 min work/2 min rest | Acute | 88% VO2max
| Plasma | Immediately, 1.5, 6 and 23 h after exercise | Increase of soluble interleukin-6 receptor complex plasma levels (159%) and increase of IL-6 plasma levels (2.5-fold) immediately after HIT |
|
| ||||||||||
| Lyngsø et al., 2002 [ | 9 CON | 24 ± 1 | ET | Cycling | 60 min | Acute | 60% VO2max | Plasma | During, immediately and 3 h after exercise | Increase of IL-6 plasma levels (17-fold) during and 30 min after exercise |
|
| ||||||||||
| Keller et al., 2001 [ | 6 untrained CON | 26 ± 4 | ET | Two-legged knee extensor apparatus | 180 min | Acute | 60% of maximum workload of 2 min | Plasma | Immediately, 30, 60, 90 and 180 min after exercise | Increase of IL-6 and TNF- |
|
| ||||||||||
| Febbraio et al., 2004 [ | 6 trained CON | 24 ± 1 | ET | Cycling | 120 min | Acute | 40% VO2max
| Plasma | During (every 30 min), immediately, 60 and 120 min after exercise | Increase of IL-6 plasma levels at 70% of VO2max 60 min after exercise, no change at 40% of VO2max |
|
| ||||||||||
| Ostrowski et al., 1998 [ | 16 trained CON | 31 ± 2 | ET | Marathon | 42.2 km | Acute | n.r. | Plasma | Immediately and 2 h after exercise | Increase of IL-6 (62.0-fold), IL-1 receptor antagonist (23.0-fold), TNF- |
|
| ||||||||||
| Ostrowski et al., 1999 [ | 10 trained CON | 28 ± 5 | ET | Marathon | 42.2 km | Acute | n.r. | Plasma | Immediately, and every 30 min until 4 h after exercise | Increase of IL-6 plasma levels (128.0-fold) peaked immediately after exercise and increase of IL-1 receptor antagonist (39.0-fold), TNF- |
|
| ||||||||||
| Starkie et al., 2001 [ | 5 trained CON | n.r. | ET | Marathon | 150–200 min | Acute | n.r. | Plasma | Immediately, 2 h and 24 h after exercise | Increase of IL-6 and TNF- |
|
| ||||||||||
|
Oliveira and Gleeson, 2010 [ | 9 trained CON | 25 ± 5 | ET | Cycling | 90 min | Acute | 75% VO2max | Plasma | Immediately, 2 and 4 h after exercise | Decrease of monocyte TLR4 protein content expression immediately (32%) and 1 h (45%) after exercise |
|
| ||||||||||
| Galpin et al., 2012 [ | 9 trained CON | n.r. | RT | Dynamic pull exercise | 15 sets × 3 repetitions | Acute | 85% 1-RM | Muscle | During and immediately after exercise | Increase of MAPK (3-fold) and JNK (2.4-fold) phosphorylation |
|
| ||||||||||
| Suzuki et al., 2000 [ | 16 trained CON | n.r. | ET | Marathon | n.r. | Acute | n.r. | Plasma | Immediately after exercise | Increase of IL-6 and IL-1 receptor antagonist plasma levels by 100-fold, decrease of IL-2 by 32% after exercise |
|
| ||||||||||
| Boppart et al., 2000 [ | 14 trained CON | 32 ± 2 | ET | Marathon | 42.2 km | Acute | n.r. | Muscle | Immediately, 1 day, 3 days and 5 days after exercise | Increase of JNK activity immediately after exercise (5-fold), but diminished in the following days |
|
| ||||||||||
| Aronson et al., 1998 [ | 8 CON | 30 ± 12 | ET | Cycling | 60 min | Acute | 70% VO2max | Muscle | Immediately after exercise | Increase of JNK activity immediately after exercise (6-fold) |
|
| ||||||||||
| Punyadeera et al., 2005 [ | 10 trained CON | 23 ± 1 | ET | Cycling | 120 min | Acute | 50% | Plasma & muscle | Immediately and 2 h after exercise | No change in adiponectin plasma levels and adiponectin receptor expression in muscle |
|
| ||||||||||
| Jürimäe et al., 2006 [ | 8 trained CON | 63 ± 1 | ET | Rowing | 6.5 km | Acute | 76% VO2max | Plasma | Immediately and 30 min after exercise | Increase of adiponectin plasma levels (15%) 30 min after exercise |
|
| ||||||||||
| Fatouros et al., 2005 [ | 50 untrained CON | 65–78 | RT | Weight machine | 3 × 60 min | Chronic (24 weeks) | 3-4 sets of 4–12 repetitions with 45–85% of 1-RM | Plasma | 48 h after exercise | Increase of adiponectin plasma levels in high-intensity group (60%) and medium-intensity group (18%), still elevated in HI group after 24 weeks of detraining (32%) |
|
| ||||||||||
| Kriketos et al., 2004 [ | 19 sedentary obese CON | 37 ± 1 | ET | Brisk walking/jogging | 4-5 × 40 min | Chronic (10 weeks) | 55–70% VO2max | Plasma | 48 h after exercise | Increase of adiponectin plasma levels by 230% |
|
| ||||||||||
| Lim et al., 2008 [ | 36 CON (young), | 22 ± 3 | ET | Cycling | 3 × 60 min | Chronic (10 weeks) | 70% VO2max | Plasma | Immediately after exercise | Increase of adiponectin plasma levels in young (20%) and middle-aged women (27%) |
|
| ||||||||||
| Kondo et al., 2006 [ | 8 untrained obese CON, | 18 ± 1 | ET | Walking/jogging | 4-5 × 30 min | Chronic (28 weeks) | 60–70% HRR | Plasma | Immediately after exercise | Increase of adiponectin plasma levels in obese CON (75%) and no change in lean CON; |
|
| ||||||||||
| Rodriguez-Miguelez et al., 2014 [ | 16 untrained CON | 70 ± 1 | RT | Leg press, pec deck, biceps curl | 2 × 3 sets per 3 exercises | Chronic (8 weeks) | 50–80% 1-RM | Plasma | 5-6 days after training | Decrease of TLR2 and TLR4 protein content expression and no change in TNF- |
|
| ||||||||||
| O'Leary et al., 2006 [ | 16 untrained obese CON | 63 ± 1 | ET | Running/cycling | 5 × 60 min | Chronic (12 weeks) | 85% HRmax | Plasma | 18 h after exercise | No change in adiponectin plasma levels |
|
| ||||||||||
| Kadoglou et al., 2007 [ | 30 untrained T2D | 57 ± 7 | ET | Walking, running, cycling | 4 × 45–60 min | Chronic (16 weeks) | 50–85% VO2max | Plasma | 48 h after exercise | Decrease of IL-6 (33%) and IL-18 (40%) plasma levels in T2D after exercise |
|
| ||||||||||
| Leick et al., 2007 [ | 13 untrained obese CON, | 36 ± 4 | ET | Cycling | 90–120 min | Acute | 60–70% VO2max
| Adipose tissue | Immediately, 2 and 10 h after exercise | No change of IL-18 mRNA expression after acute exercise in each time point; |
|
| ||||||||||
| Sriwijitkamol, et al., 2006 [ | 8 untrained CON, | 36 ± 3 | ET | Cycling | 4 × 45 min | Chronic (8 weeks) | 70% VO2max | Muscle | 24–36 h after exercise | Increase in I |
|
| ||||||||||
| Gray et al., 2009 [ | 24 untrained CON | 49 ± 9 | ET | Community-based walking | 5 times | Chronic (12 weeks) | >3000 steps per day | Plasma | n.r. | No change in IL-6, TNF- |
Data are given as mean ± SD for age; all changes given in the table were statistically significant; CON, controls; ET, endurance training; HI, high-intensity; HIT, high-intensity interval training, HRmax maximum heart rate, HRR, heart rate reserve; hs-CRP, high-sensitive C-reactive protein; IκBα/β, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha/beta; IL-2, interleukin 2; IL-6, interleukin 6; IL-10, interleukin 10; IL-18, interleukin 18; JNK, C-Jun N-terminal kinase; MAPK, mitogen-activated protein kinase; mRNA, messenger RNA; n.r., not reported; RM, one repetition maximum; RT, resistance training; T2D, type 2 diabetes; TLR2, Toll-like receptor 2, TLR4, Toll-like receptor 4, TNF-α, tumor necrosis factor alpha; VO2max, maximum oxygen consumption; W max, maximum Watt.
Influence of exercise on inflammatory signaling and adiponectin in animal models.
| Reference | Animals, | Age, week | Training modality | Type of sport | Training frequency | Acute/chronic exercise | Training intensity | Tissue & condition | Time since the last exercise bout, h | Changes in cytokines and related inflammatory signaling |
|---|---|---|---|---|---|---|---|---|---|---|
| Oliveira et al., 2011 [ | Male Wistar rats with HFD | 8 | ET | Swimming | 2 × 180 min | Acute | Additional weight of 5% of body weight | Adipose, muscle & hepatic tissue | 2, 16, 24, and 36 h after exercise | Decrease in TLR4 mRNA and protein expression in all tissues and reduction in JNK and IKK |
|
| ||||||||||
| Castellani et al., 2015 [ | Male untrained C57BL/6J mice, | 10 | ET | Treadmill running | 120 min | Acute | 15 m/min–19 m/min (50% maximal running speed) | Adipose tissue & plasma | Immediately and 4 h after exercise | Increase of IL-6 and IL-6 R |
|
| ||||||||||
| Whitham et al., 2012 [ | Male untrained C57BL/6 mice (CON), | n.r. | ET | Treadmill running | 30–60 min | Acute | 0.22–0.25 m/s | Muscle | Immediately and 30 min after exercise | Increase of muscle IL-6 mRNA expression 30 min after exercise in CON; |
|
| ||||||||||
| Macpherson et al., 2015 [ | Male untrained C57BL/6J mice fed with HFD | 7 | ET | Treadmill running | 120 min | Acute | 15 m/min - 5% incline | Adipose tissue | Immediately and 2 h after exercise | Increase of MCP-1 mRNA (2-fold) immediately after exercise and increase of IL-6, MCP-1 (10-fold) and IL-10 (5-fold) mRNA after 2 hours |
|
| ||||||||||
| Kawanishi et al., 2013 [ | 12 male C57BL/6J mice with HFD, 12 C57BL/6J mice with ND | 4 | ET | Treadmill running | 5 × 60 min | Chronic (16 week) | 15 m/min–20 m/min | Adipose tissue & liver | 72 h after exercise | Higher levels of TNF |
|
| ||||||||||
| Cho et al., 2016 [ | 10 untrained C57BL/6 mice with HFD | 15 | HIT | Treadmill running | 40 min | Chronic (8 weeks) | 10–17 m/min | Muscle | Immediately after exercise | Prevention of downregulation of AdipoR1 expression caused by HFD |
|
| ||||||||||
| Ritchie et al., 2014 [ | Male wild-type (WT, C57BL/6J), adiponectin knockout (AdKO, B6.129-Adipoqtm1Chan/J) mice | 12 | ET | Treadmill running | 3 × 45–60 min | Chronic (8 weeks) | 5 × 20–32 m/min | Muscle | 48 h after exercise | Increase in total AS160 from AdKO (44%) compared to WT mice (28%); |
|
| ||||||||||
| da Luz et al., 2011 [ | Obese DIO rats | n.r. | ET | Swimming | 5 × 60 min | Chronic (8 weeks) | Additional weight of 5% of body weight | Adipose tissue & hepatic tissue | Immediately after exercise | Decrease of JNK, I |
|
| ||||||||||
| Medeiros et al., 2011 [ | Obese Wistar rats with HFD | n.r. | ET | Swimming | n.r. | Chronic (12 weeks) | n.r. | Adipose tissue | n.r. | Increase in Akt (2.3-fold) and Foxo1 (1.7-fold) phosphorylation, reduction in phospho-JNK (1.9-fold), NF-kB (1.6-fold) and PTP-1B (1.5-fold) protein expression, and increase in mTOR (1.7-fold), p70S6k (1.9-fold), and 4E-BP1 phosphorylation (1.4-fold) after exercise training |
|
| ||||||||||
| Oliveira et al., 2011 [ | Male Wistar rats with HFD | 8 | ET | Swimming | 5 × 60 min | Chronic (8 weeks) | Additional weight of 5% of body weight | Adipose, muscle & hepatic tissue | 24 and 36 h after exercise | Decrease in TLR4 mRNA and protein expression and reduction of JNK and IKK |
|
| ||||||||||
| Passos et al., 2015 [ | Male Sprague-Dawley rats with HFD | 5-6 | ET | Treadmill running | 5 × 60 min | Chronic (8 weeks) | 15–25 m/min | Plasma | Immediately after exercise | Decrease in JNK activation and total JNK level in HFD compared to sedentary HFD |
|
| ||||||||||
| Mardare et al., 2016 [ | Male C57BL/6 mice | 10 | ET | Treadmill running | 5 × 30 min | Chronic (10 weeks) | 80% VO2max | Serum & adipose tissue | 72 h after exercise | Decrease of IL-18 and TNF- |
|
| ||||||||||
| Mardare et al., 2016 [ | Male C57BL/6 mice | 10 | RT | Isometric strength training | 5 × 3 min with 3 sets | Chronic (10 weeks) | n.r. | Serum & adipose tissue | 72 h after exercise | Decrease of IL-18 serum levels |
All changes given in the table were statistically significant; CON, controls; DIO, diet-induced obesity; ES, electrical stimulation; ET, endurance training; GLUT4, glucose transporter 4; HFD, high fed diet; HI, high-intensity; HIT, high-intensity interval training; hs-CRP, high-sensitive C-reactive protein; IκBα/β, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha/beta; IL-6, interleukin 6; IL-6 Rα, interleukin 6 receptor α; IL-10, interleukin 10; IRS-1, insulin receptor substrate 1; JNK, C-Jun N-terminal kinase; MCP-1, monocyte chemotactic protein 1; mRNA, messenger RNA; ND, normal diet; NF-κB, nuclear factor kappa; n.r., not reported; RT, resistance training; TNF-α, tumor necrosis factor alpha; TLR4, Toll-like receptor 4.
Figure 1Interaction of important key players in exercise mediated glucose uptake of human muscle cells. A proposed model for the key players in glucose transport after physical exercise. αPKC, atypical PKC; AMP, adenosine monophosphate; AMPK, AMP-activated protein kinase; AS160, Akt substrate of 160 kDa; Ca, calcium; CaMKII, Ca2+/calmodulin-dependent protein kinase 2; Cr, creatine; GLUT-4, glucose transporter 4; HDAC4/5, histone deacetylase 4/5; IL-6, interleukin 6; IRS-1, insulin receptor substrate 1; LKB-1, liver kinase B1; MEF2, myocyte enhancer factor-2; MAPK, mitogen-activated protein kinases; mTOR, mammalian target of rapamycin (C1 complex 1 and C2 complex 2); PDK, phosphoinositide-dependent kinase; PI3-K, phosphoinositide 3-kinase; PKB, protein kinase B; Rac1, ras-related C3 botulinum toxin substrate 1; TBC1D1, TBC1 domain family member 1; TNF-α, tumor necrosis factor alpha; WAT, white adipose tissue.